Depression-like syndrome in rats induced by neurotoxin MPTP and autoantibodies to serotonin and dopamine

Zhurnal Vysshei Nervnoi Deyatelnosti Imeni I.P. Pavlova

Volumn 47, Issue 4, 1997, Pages 731-739

  Vetrile, L A ^a   Krupina, N A ^a   Basharova, L A ^a   Kryzhanovsky, G N ^a   Evseev, V A ^a   Orlova, I N ^a   Iordanskaya, T E ^a  

^a INSTITUTE OF GENERAL PATHOLOGY AND PATHOPHYSIOLOGY   (Russian Federation)

Author keywords

[No Author keywords available]

Indexed keywords

1,2,3,6 TETRAHYDRO 1 METHYL 4 PHENYLPYRIDINE; AUTOANTIBODY; DOPAMINE; NEUROTOXIN; SEROTONIN;

ANALYSIS OF VARIANCE; ANIMAL; ANTIBODY SPECIFICITY; ARTICLE; BLOOD; CHEMICALLY INDUCED DISORDER; DEPRESSION; DISEASE MODEL; DRUG EFFECT; ENZYME LINKED IMMUNOSORBENT ASSAY; IMMUNOLOGY; MALE; RAT; TIME; WISTAR RAT;

1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE; ANALYSIS OF VARIANCE; ANIMALS; ANTIBODY SPECIFICITY; AUTOANTIBODIES; DEPRESSIVE DISORDER; DISEASE MODELS, ANIMAL; DOPAMINE; ENZYME-LINKED IMMUNOSORBENT ASSAY; MALE; NEUROTOXINS; RATS; RATS, WISTAR; SEROTONIN; TIME FACTORS;

EID: 0031182090     PISSN: 00444677     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (24)

1. Becth. AMH CCCP. 1988. No 3. C. 10.
2. Brown A.S., Gershon S. Dopamine and depression // J. Neural Transmis. 1993. V. 91. P. 75.
3. De Simoni M.G., Dal Toso G., Fodritto F. et al. Modulation of striatal dopamine metabolism by the activity of dorsal raphe serotoninergic afferentes // Brain Res. 1987. V. 411. P. 81.
4. Fibiger H.C. Neurobiology of Depression: Focus on Dopamine // Depression and Mania. From Neurobiology to Treatment / Eds G. Gessa, W. Fratta, G. Serra. N.Y.: Raven Press, 1995. P. 1.
5. Klein R., Bansch M., Berg A. Clinical relevance of antibodies in patients with primary fibromialgia syndrome // Psychoneuroendocrinology. 1992. V. 17. P. 593.
6. Mayeux R., Stern Y., Sano M. et al. The relationship of serotonin to depression in Parkinson's disease // Mov. Disord. 1988. V. 3. P. 237.
7. Meltzer H.Y., Lowy M.T. Serotonin Hypothesis of Depression // Psychopharmacology: The Third Generation of Progress / Ed. H.Y. Meltzer. N.Y.: Raven Press, 1987. P. 513.
8. Nathan K.I., Musselman D.L., Schatzberg A.F. et al. Biology of Mood Disorders // Textbook of Phychopharmacology / Eds A.F. Schatzberg, Ch.B. Nemeroff. Washington, London: The Amer. Psychiatr. Press, Inc., 1995. P. 439.
9. Plaznik A., Kostowski W., Archer T. Serotonin and depression: old problems and new data // Progr. Neuro-Psychopharmacol. and Biol. Psychiatr. 1989. V. 13. P. 623.
10. Roy B.F., Rose J.W., McFarland H.F. et al. Anti-β-endorphin immunoglobulin G in humans // Proc. Nat. Acad. Sci. U.S.A. 1986. V. 83. P. 8739.
11. Schott K., Batra A., Klein R. et al. Antibodies against serotonin and gangliozides in schizophrenia and major depressive disorder // Europ. Psychiatry. 1992. V. 7. P. 209.